concerns, potentially fatal, typical of the TNF class. According to the product labeling, after a number of studies and reports of adverse events in patients receiving adalimumab, including serious and sometimes fatal blood disorders
; serious infections including include TB (tuberculosis) and infections caused by viruses, fungi, or bacteria; rare reports of lymphoma and solid tissue cancers; rare reports of serious liver injury; and rare reports of demyelinating central
nervous system disorders); rare reports of cardiac failure; the U.S. Food and Drug Administration issued a black box warning to doctors appearing in the product labeling of adalimumab and the other TNF drugs instructing them to screen and monitor potential patients more carefully.
ref:http://en.wikipedia.org/wiki/Humira
You have to take it only under medical supervision and not self-medicate with drug.
At the first sign of any of the adverse effects mentioned .stop taking it and report to the doctor immediately.